PodcastIntel
Sign in Get Started Free
Urology Times
Urology Times

Why ctDNA serves as a rule-out in NeoBLAST's response assessment

Oct 8, 2026 · 0:06:56
✨ AI Summary
  • NeoBLAST uses imaging, TURBT, and ctDNA for bladder-sparing surveillance.
  • ctDNA acts as a rule-out tool for treatment response.
  • Identifies candidates for surveillance after initial treatment.

Guests on This Episode

MS
Marie-Pier St-Laurent
1 podcast appearance

More from Urology Times

View all episodes →

Get AI Summaries for Every New Episode

Subscribe to Urology Times and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →